Notes

Book germline mutation KMT2A G3131S confers hereditary the likelihood of genetic myeloproliferative neoplasms.
We observed an intensity-dependent photothermal g-factor from chiral helicoids that decreases slightly at higher temperatures. We also measure a range of optical g-factors from several gold helicoids, which are attributed to the heterogeneity of helicoids in nanoparticles during synthesis. The principles of differential photothermal response of chiral nanomaterials and heat generation described here can be potentially used for thermal photocatalysis, energy conversion, and electronic applications.A new 96-well plate methodology for fast, enzyme-multiplexed screening for metabolite-protein adducts was developed. Magnetic beads coated with metabolic enzymes were used to make potentially reactive metabolites that can react with test protein in the wells, followed by sample workup in multiple 96-well filter plates for LC-MS/MS analysis. Incorporation of human microsomes from multiple organs and selected supersomes of single cytochrome P450 (cyt P450) enzymes on the magnetic beads provided a broad spectrum of metabolic enzymes. The reacted protein was then isolated, denatured, reduced, alkylated, and digested, and peptides were collected in a sequence of 96-well filter plates for analysis. Method performance was evaluated by trapping acetaminophen reactive metabolite N-acetyl-p-benzoquinoneimine (NAPQI) with human glutathione S-transferase pi (hGSTP), human serum albumin (HSA), and bovine serum albumin (BSA) as model target proteins. Relative amounts of acetaminophen metabolite and hGSTP adducts were compared with 10 different cyt P450 enzymes. Human liver microsomes and CYP1A2 supersomes showed the highest bioactivation rate for adduct formation, in which all four cysteines of hGSTP reacted with NAPQI. Eight cysteines of HSA and four cysteines of BSA have been detected to react with NAPQI. This method has the potential for fast multienzyme protein adduct screening with high efficiency and accuracy.A new concept for the direct ink writing (DIW) of model titanium dioxide inks through capillary action (no applied pressure during printing) is investigated through the use of diluted low viscosity inks for micropatterning. The inks are characterized with respect to rheological, thermal, and surface properties. Printed structures are characterized by profilometry, atomic force microscopy (AFM), scanning electron microscopy (SEM), and photocatalytic degradation of methylene blue. By use of the concept of surface force-driven DIW and by control of the writing speed and ink composition for different substrate surfaces, the heights of profiles of printed structures can be tailored from under 100 nm to over 1 μm. Furthermore, it is demonstrated that the surface roughness of the titanium dioxide films can be reduced up to 60% by increasing writing speed and line-to-line spacing. This work highlights a new concept of low viscosity solution micropatterning that currently can only be performed by other methods such as inkjet printing. It is believed that this novel approach will hold the key to patterning a range of low viscosity inks for various thin film technological applications.As genome sequencing methodologies have become more sensitive in detecting low-frequency rare-variant events, the link between post-zygotic mutagenesis and somatic mosaicism in the etiology of several human genetic conditions other than cancers has become more clear. Given that current clinical-genomics diagnostic methods have limited detection sensitivity for mosaic events, a copy-number variant (CNV) deletion inherited from a parent with low-level ( less then 10%) mosaicism can be erroneously interpreted in the proband to represent a de novo germline event. Here, we describe three sensitive, precise, and cost-efficient methods that can quantitatively assess the potential degree of parental somatic mosaicism levels for CNV deletions droplet digital PCR (ddPCR), PCR amplicon-based next-generation sequencing (NGS), and quantitative PCR. ddPCR using the EvaGreen fluorescent dye protocol can specifically quantify the deleted or non-deleted alleles by analyzing the number of droplets positive for a fluorescent signal for each event. PCR amplicon-based NGS assesses the allele frequencies of a heterozygous single-nucleotide polymorphism within a deletion region. The difference in number of reads between the two genotypes indicates the level of somatic mosaicism for the CNV deletion. Quantitative PCR can be applied where the relative quantity of the deletion junction-specific product represents the level of mosaicism. Clinical implementation of these quantitative variant-detection methods enables potentially more accurate assessment of disease recurrence risk in family-based genetic counseling, allowing couples to engage in more informed family planning. © 2020 by John Wiley & Sons, Inc. Basic Protocol Droplet digital PCR (ddPCR) Alternate Protocol 1 PCR amplicon-based next-generation sequencing Alternate Protocol 2 Quantitative real-time PCR (qPCR).Clinical interpretation of DNA sequence variants is a critical step in reporting clinical genetic testing results. SBI-115 Application of next-generation sequencing technology in molecular genetic testing has facilitated diagnoses of genetic disorders in clinical practice. However, the large number of DNA sequence variants detected in clinical specimens, many of which have never been seen before, make clinical interpretation challenging. Recommendations by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) have been widely adopted by clinical laboratories around the world to guide clinical interpretation of sequence variants. The ClinGen Sequence Variant Interpretation Working Group and various disease-specific variant curation expert panels have also developed specifications for the ACMG/AMP recommendations. Despite these efforts to standardize variant interpretation in clinical practice, different laboratories may subjectively use professional judgment to determine which criteria are applicable when classifying a variant. In addition, clinicians and researchers who are not familiar with the variant interpretation process may have difficulty understanding clinical genetic reports and communicating the clinical significance of genetic testing results. Here we provide a step-by-step protocol for clinical interpretation of sequence variants, including practical examples. By following this protocol, clinical laboratory geneticists can interpret the clinical significance of sequence variants according to the ACMG/AMP recommendations and ClinGen framework. Furthermore, this article will help clinicians and researchers to understand variant classification in clinical genetic testing reports and evaluate the quality of the reports. © 2020 by John Wiley & Sons, Inc. Basic Protocol Interpreting the clinical significance of sequence variants Support Protocol Reevaluating the clinical significance of sequence variants.
Homepage: https://www.selleckchem.com/products/sbi-115.html